Skip to main content

Advertisement

Log in

Visual functional defects in patients with type 2 diabetes mellitus: a questionnaire based cross-sectional study

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To determine the impact of type 2 diabetes mellitus (T2DM) on visual functions, identify different modifiers as risk or protective factors, and find out how these factors affect patients’ visual symptoms and visual functions as a whole.

Methods

We performed an online survey among 1030 participants (400 patients, 630 non-patients). Demographic features and severity of disease were documented, while visual functions were evaluated using National Eye Institute Visual Functioning questionnaire-25 (NEI VFQ-25). Independent t-test, analysis of variance, linear and nonlinear regression models were used to assess all data.

Results

Scores other than color vision among T2DM patients were significantly lower compared with non-T2DM participants. There was significant difference after stratification of age and education, but no significant difference between different genders was observed. Parameters including duration of T2DM, fasting plasma glucose (FPG) and glycosylated hemoglobin A1c (HbA1c) negatively impacted on the scores, with 20 years’ of diabetic duration, 10 mmol/L of FPG, 7.5% of HbA1c being potential cut-off points. Poorer best corrected visual acuity (BCVA) and diagnosis of diabetic retinopathy were risk factors, while they simultaneously produced mediation effect, contributing 5%-78% of effect in the deterioration of visual functions caused by longer diabetic duration and higher blood glucose.

Conclusion

Significant visual impairments and faster deterioration in visual functions were seen in T2DM patients, with older age, lower educational level, longer diabetic duration, poorer blood glucose administration, limited BCVA, and the presence of diabetic retinopathy identified as risk factors. Average BCVA and diabetic retinopathy also yielded mediation effect as diabetic duration lengthened and blood glucose elevated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lancet T (2020) Diabetes Endocrinology Under the lens: diabetic retinopathy. Lancet Diabetes Endocrinol 8(11):869. https://doi.org/10.1016/S2213-8587(20)30347-8 (Epub 2020 Oct 7 PMID: 33038294)

    Article  Google Scholar 

  2. Ogurtsova K, da Rocha Fernandes JD, Huang Y (2017) IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024

    Article  CAS  PubMed  Google Scholar 

  3. Heng LZ, Comyn O, Peto T (2013) Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 30(6):640–650. https://doi.org/10.1111/dme.12089

    Article  CAS  PubMed  Google Scholar 

  4. Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R (2016) Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res 2016:2156273. https://doi.org/10.1155/2016/2156273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Khan A, Petropoulos IN, Ponirakis G, Malik RA (2017) Visual complications in diabetes mellitus: beyond retinopathy. Diabet Med. https://doi.org/10.1111/dme.13296

    Article  PubMed  Google Scholar 

  6. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study [published correction appears in Lancet Glob Health. 2021 Apr;9(4):e408]. Lancet Glob Health. https://doi.org/10.1016/S2214-109X(20)30489-7

  7. Ting DS, Cheung GC, Wong TY (2016) Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. https://doi.org/10.1111/ceo.12696

    Article  PubMed  Google Scholar 

  8. Yin L, Zhang D, Ren Q, Su X, Sun Z (2020) Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000019236

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wat N, Wong RL, Wong IY (2016) Associations between diabetic retinopathy and systemic risk factors. Hong Kong Med J. https://doi.org/10.12809/hkmj164869

  10. Siersma V, Køster-Rasmussen R, Bruun C, Olivarius NF, Brunes A (2019) Visual impairment and mortality in patients with type 2 diabetes. BMJ Open Diabetes Res Care. https://doi.org/10.1136/bmjdrc-2018-000638

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cusick M, SanGiovanni JP, Chew EY, Csaky KG, Hall-Shimel K, Reed GF, Caruso RC, Ferris FL 3rd (2005) Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol 139(6):1042–1050. https://doi.org/10.1016/j.ajo.2005.01.008

    Article  PubMed  Google Scholar 

  12. Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., Hays, R. D., & National Eye Institute Visual Function Questionnaire Field Test Investigators (2001) Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology (Chicago, Ill: 1960), 119(7), 1050–1058. https://doi.org/10.1001/archopht.119.7.1050

  13. Fenwick EK, Man REK, Gan ATL et al (2019) Beyond vision loss: the independent impact of diabetic retinopathy on vision-related quality of life in a Chinese Singaporean population. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2018-313082

    Article  PubMed  Google Scholar 

  14. Schuster AK, Pfeiffer N, Schulz A et al (2017). The impact of pseudophakia on vision-related quality of life in the general population - The Gutenberg Health Study. Aging (Albany NY). https://doi.org/10.18632/aging.101208

  15. Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L (2008) Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol 92(1):89–92. https://doi.org/10.1136/bjo.2007.122416

    Article  CAS  PubMed  Google Scholar 

  16. Trento M, Passera P, Trevisan M, Schellino F, Sitia E, Albani S, Montanaro M, Bandello F, Scoccianti L, Charrier L, Cavallo F, Porta M (2013) Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study. Acta Diabetol 50(6):873–877. https://doi.org/10.1007/s00592-013-0470-1

    Article  PubMed  Google Scholar 

  17. Araki A, Ito H (2009) Diabetes mellitus and geriatric syndromes. Geriatr Gerontol Int 9(2):105–114. https://doi.org/10.1111/j.1447-0594.2008.00495.x

    Article  PubMed  Google Scholar 

  18. Man REK, Gan ATL, Fenwick EK et al (2021) The differential impact of age on vision-related quality of life across the visual impairment spectrum. Ophthalmology. https://doi.org/10.1016/j.ophtha.2020.07.046

    Article  PubMed  Google Scholar 

  19. Song P, Yu J, Chan KY, Theodoratou E, Rudan I (2018) Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health 8(1):010803. https://doi.org/10.7189/jogh.08.010803

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ben Mehidi A, Massin P, Guyot-Argenton C, Erginay A, Guillausseau PJ, Gaudric A (2003) La rétinopathie diabétique du sujet jeune: l’enfant et l’adolescent [Diabetic retinopathy in children and adolescents]. Diabetes Metab 29(3):300–306

    Article  CAS  Google Scholar 

  21. Danet-Lamasou M, Pérès K, Matharan F, Berr C, Carrière I, Tzourio C, Delcourt C, Bourdel-Marchasson I (2018) Near Visual Impairment Incidence in Relation to Diabetes in Older People: The Three-Cities Study. J Am Geriatr Soc 66(4):699–705

    Article  Google Scholar 

  22. de Fine Olivarius N, Siersma V, Almind GJ, Nielsen NV (2011) Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study. BMC Public Health 11:80. https://doi.org/10.1186/1471-2458-11-80

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kajiwara A, Miyagawa H, Saruwatari J, Kita A, Sakata M, Kawata Y, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K (2014) Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study. Diabetes Res Clin Pract 103(3):e7–e10. https://doi.org/10.1016/j.diabres.2013.12.043

    Article  CAS  PubMed  Google Scholar 

  24. Ozawa GY, Bearse MA Jr, Adams AJ (2015) Male-female differences in diabetic retinopathy? Curr Eye Res 40(2):234–246. https://doi.org/10.3109/02713683.2014.958500

    Article  CAS  PubMed  Google Scholar 

  25. Maric-Bilkan C. (2017) Sex differences in micro- and macro-vascular complications of diabetes mellitus. Clinical science (London, England: 1979), 131(9), 833–846. https://doi.org/10.1042/CS20160998

  26. Zoungas S, Woodward M, Li Q et al (2014) Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. https://doi.org/10.1007/s00125-014-3369-

    Article  PubMed  Google Scholar 

  27. Taylor SI, Yazdi ZS, Beitelshees AL (2021) Pharmacological treatment of hyperglycemia in type 2 diabetes. J Clin Invest. https://doi.org/10.1172/JCI142243

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gebreyohannes EA, Netere AK, Belachew SA (2019) Glycemic control among diabetic patients in Ethiopia: A systematic review and meta-analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0221790

    Article  PubMed  PubMed Central  Google Scholar 

  29. Foo V, Quah J, Cheung G, Tan NC, Ma Zar KL, Chan CM, Lamoureux E, Tien Yin W, Tan G, Sabanayagam C (2017) HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics. J Diabetes 9(2):200–207. https://doi.org/10.1111/1753-0407.12403

    Article  CAS  PubMed  Google Scholar 

  30. Kahloun R, Jelliti B, Zaouali S, Attia S, Ben Yahia S, Resnikoff S, Khairallah M (2014) Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa. Eye (Lond) 28(8):986–991. https://doi.org/10.1038/eye.2014.131

    Article  CAS  Google Scholar 

  31. Liu Y, Duan C, Fang D, Liu Y, Xu H, Zheng Y, Xuan Y, Wang L, Ye L, Su R, An M (2019) Protective factors for diabetic retinopathy in Type 2 diabetes mellitus patients: Long duration of no less than 10 years. J Diabetes Complications 33(10):107383. https://doi.org/10.1016/j.jdiacomp.2019.05.014

    Article  PubMed  Google Scholar 

  32. Škrha J, Šoupal J, Škrha J Jr, Prázný M (2016) Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord 17(1):103–110. https://doi.org/10.1007/s11154-016-9347-2

    Article  CAS  PubMed  Google Scholar 

  33. Hsieh YT, Hsieh MC (2020) Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study. Clin Experiment Ophthalmol 48(4):470–476. https://doi.org/10.1111/ceo.13728

    Article  PubMed  Google Scholar 

  34. Lim HB, Shin YI, Lee MW, Lee JU, Lee WH, Kim JY (2020) Association of myopia with peripapillary retinal nerve fiber layer thickness in diabetic patients without diabetic retinopathy. Invest Ophthalmol Vis Sci 61(10):30. https://doi.org/10.1167/iovs.61.10.30

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Feitosa-Santana C, Paramei GV, Nishi M, Gualtieri M, Costa MF, Ventura DF (2010) Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge Colour Test. Ophthalmic & Physiological Optics: the Journal of the British College of Ophthalmic Opticians (Optometrists) 30(5):717–723. https://doi.org/10.1111/j.1475-1313.2010.00776.x

    Article  Google Scholar 

  36. Wolff BE, Bearse MA Jr, Schneck ME, Dhamdhere K, Harrison WW, Barez S, Adams AJ (2015) Color vision and neuroretinal function in diabetes. Documenta Ophthalmologica Advances in Ophthalmology 130(2):131–139. https://doi.org/10.1007/s10633-014-9476-4

    Article  CAS  PubMed  Google Scholar 

  37. Hautala N, Aikkila R, Korpelainen J, Keskitalo A, Kurikka A, Falck A, Bloigu R, Alanko H (2014) Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmol 92(6):582–587. https://doi.org/10.1111/aos.12278

    Article  PubMed  Google Scholar 

  38. Hu Y, Niu Y, Wang D, Wang Y, Holden BA, He M (2015) The association of longitudinal trend of fasting plasma glucose with retinal microvasculature in people without established diabetes. Invest Ophthalmol Vis Sci 56(2):842–848. https://doi.org/10.1167/iovs.14-15943

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by Beijing Key Laboratory Opening Funding (Grant number: BKLOF-BYSY202101).

Author information

Authors and Affiliations

Authors

Contributions

Study design and concept: SC, JY, XL; Data collection and analysis: YG, YW; Interpretation of data and critical revision of the manuscript: SC, YG, HX, RD, XR, HY, QH, JY; All authors have read and approved the final draft of the manuscript submitted.

Corresponding authors

Correspondence to Jiarui Yang or Xuemin Li.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee (Peking University Third Hospital Medical Science Research Ethics Committee, S2020023) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 26 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chai, S., Ge, Y., Wan, Y. et al. Visual functional defects in patients with type 2 diabetes mellitus: a questionnaire based cross-sectional study. Int Ophthalmol 42, 2205–2218 (2022). https://doi.org/10.1007/s10792-022-02220-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-022-02220-w

Keywords

Navigation